EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Formulation development of ranitidine with nanoparticles for enhancement of efficacy

Naseer Ahmed

Pharmaceutical Communications · 2024

DOI: 10.55627/pharma.003.002.01085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Communications, 2024. Verfasst von Naseer Ahmed. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the current world, various forms of cardiovascular diseases such as hypertension, stroke, heart failure, and arrhythmias— along with other diseases —critically impact a person’s life and overall well-being. It is becoming a global challenge to overcome these diseases (Li 2023). In 2021 the approximate number of patients suffering from cardiovascular diseases globally was 20.5 million and the predicted cardiovascular death rate of any given year over the ensuing hundred years in any country was estimated to be about 1.05% (Oleg Gaidai 2023b). Symptoms of cardiovascular diseases vary from patient to patient (Corrine Y. Jurgens 2022) and can be caused by various factors such as smoking, diet, unhealthy lifestyle, obesity, and diabetes. (Dahlöf 2010, R. Nangia 2016). Coronary artery disease most commonly arises as a result of cholesterol buildup in the coronary artery or due to damage of the arterial lining causing a decrease in blood supply to the heart (Peter Libby 2005, Valentin Fuster 1992).

Zitieren

APA

Ahmed, N. (2024). Formulation development of ranitidine with nanoparticles for enhancement of efficacy. Pharmaceutical Communications. https://doi.org/10.55627/pharma.003.002.01085

Vancouver

Ahmed N. Formulation development of ranitidine with nanoparticles for enhancement of efficacy. Pharmaceutical Communications. 2024. doi:10.55627/pharma.003.002.01085

BibTeX
@article{Ahmed2024,
  author = {Ahmed, Naseer},
  title = {Formulation development of ranitidine with nanoparticles for enhancement of efficacy},
  journal = {Pharmaceutical Communications},
  year = {2024},
  doi = {10.55627/pharma.003.002.01085}
}
Kostenlos starten →